1. Volume 53, Issue 6, Pages 1135-1145 (December 2010)
Renal and circulatory dysfunction in cirrhosis: Current management and future perspectives 
Elsa Solà, Pere Ginès 
Journal of Hepatology 
Volume 53, Issue 6, Pages (December 2010)
DOI: /j.jhep
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Schematic representation of the proposed pathogenesis of ascites and edema formation in cirrhosis. Established therapies are given on the left side and potential new therapies on the right. TIPS, transjugular intrahepatic portosystemic shunt.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Schematic representation of the proposed pathogenesis of hypervolemic hyponatremia in cirrhosis. Established therapies are given on the left side and potential new therapies on the right. ∗Vaptans are approved for the management of hypervolemic hyponatremia in cirrhosis in United States and Japan, but not in Europe.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Schematic representation of the proposed pathogenesis of hepatorenal syndrome in cirrhosis. Established therapies are given on the left side and potential new therapies on the right. ∗The use of TIPS, transjugular intrahepatic portosystemic shunt, has been reported in some studies but the information is very limited. ∗∗Vasoconstrictors include vasopressin analogues such as terlipressin and α-adrenergic agonists, such as norepinephrine or midodrine. ∗∗∗Albumin is given in combination with vasoconstrictors. Albumin alone is seldom effective.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

5. Journal of Hepatology 2010 53, 1135-1145DOI: (10. 1016/j. jhep. 2010
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

6. Journal of Hepatology 2010 53, 1135-1145DOI: (10. 1016/j. jhep. 2010
Copyright © 2010 European Association for the Study of the Liver Terms and Conditions